Skip to main content
Clinical Trials/DRKS00016972
DRKS00016972
Completed
N/A

Contrast-enhanced Ultrasound (CEUS) for determining muscular Perfusion after oral intake of L-Citrulline, L-Arginine, and galloylated epicatechines. - CEUS #Bizeps

niversität Heidelberg, Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie0 sites30 target enrollmentMarch 25, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Examination of different sport supplement ingredients for their potency of vasodilation in skeletal muscle.
Sponsor
niversität Heidelberg, Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie
Enrollment
30
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 25, 2019
End Date
September 30, 2020
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
niversität Heidelberg, Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie

Eligibility Criteria

Inclusion Criteria

  • Young male subjects who workout in athletic sports regularly (e.g. Fitness/Gym, weightlifting, powerlifting)

Exclusion Criteria

  • Existing contraindications for contrast agent
  • o Known intolerance for SonoVue® or other ultrasound contrast agents
  • o Cardiac Right\-to\-left shunt
  • o severe heart failure (NYHA III and IV)
  • o uncontrollable hypertension
  • o severe pulmonary hypertension(\>90 mmHg)
  • o acute respiratory distress syndrome
  • o taking Dobutamine while suffering cardiovascular instability
  • o severe pulmonary diseases, in particular severe obstructive pulmonary diseases, ARDS.
  • Known diseases of the vascular system, liver, kidneys or gastrointestinal tract

Outcomes

Primary Outcomes

Not specified

Similar Trials